POINT Biopharma

[On Demand]
Search General Info
Search Education
Search Partnering Companies
POINT Biopharma is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. In addition to our exciting pipeline of radioligand molecules for a variety of cancers, we also operate our radiopharmaceutical production facility in Indianapolis, Indiana which is capable of servicing all of North America as well as many global locations.
Ticker:
PNT
Exchange:
NASDAQ
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Indiana
Company HQ Country:
United States
Year Founded:
2019
Main Therapeutic Focus:
Lead Product in Development:
Prostate
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
POINT Biopharma